Intersect ENT

^{Priced, Nasdaq: XENT}

Sells absorbable nasal implants for post-surgical sinusitis relief.

Industry: Health Care

First Day Return: +17.5%

XENT

Sells absorbable nasal implants for post-surgical sinusitis relief.

IPO News for Intersect ENT

Sinus balloons for sale: Entellus Medical sets terms for $70 million IPO 01/15/15
US IPO Pricing Recap: The crazy chicken flies while 8 IPOs trade down or flat 07/25/14
Thursday saw four IPOs raise under $100 million; two broke issue 07/24/14

IPO Data
IPO Date	07/23/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$55
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.intersectent.com
Headquarters	Menlo Park, CA, United States
Founded	2003
Employees at IPO	146

IPO News for Intersect ENT

Intersect ENT (XENT) Performance